MX370055B - Uso de una composición que comprende aceite de pescado y jugo para el tratamiento y/o postratamiento de cáncer. - Google Patents

Uso de una composición que comprende aceite de pescado y jugo para el tratamiento y/o postratamiento de cáncer.

Info

Publication number
MX370055B
MX370055B MX2015014713A MX2015014713A MX370055B MX 370055 B MX370055 B MX 370055B MX 2015014713 A MX2015014713 A MX 2015014713A MX 2015014713 A MX2015014713 A MX 2015014713A MX 370055 B MX370055 B MX 370055B
Authority
MX
Mexico
Prior art keywords
treatment
juice
cancer
composition
fish oil
Prior art date
Application number
MX2015014713A
Other languages
English (en)
Other versions
MX2015014713A (es
Inventor
Sande Mathisen Janne
Original Assignee
Smartfish As
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=50792503&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=MX370055(B) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Smartfish As filed Critical Smartfish As
Publication of MX2015014713A publication Critical patent/MX2015014713A/es
Publication of MX370055B publication Critical patent/MX370055B/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/20—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
    • A61K31/202—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids having three or more double bonds, e.g. linolenic
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/105—Plant extracts, their artificial duplicates or their derivatives
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/115—Fatty acids or derivatives thereof; Fats or oils
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/56—Materials from animals other than mammals
    • A61K35/60—Fish, e.g. seahorses; Fish eggs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
    • A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/107—Emulsions ; Emulsion preconcentrates; Micelles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Mycology (AREA)
  • Nutrition Science (AREA)
  • Polymers & Plastics (AREA)
  • Food Science & Technology (AREA)
  • Botany (AREA)
  • Marine Sciences & Fisheries (AREA)
  • Dispersion Chemistry (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Biotechnology (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Medical Informatics (AREA)
  • Microbiology (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Inorganic Chemistry (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines Containing Plant Substances (AREA)

Abstract

La presente invención se refiere a una composición que comprende una combinación de aceite de pescado y jugo en una emulsión de aceite en agua, para usarse en el tratamiento y/o postratamiento de cáncer, en donde dicho aceite de pescado se selecciona de aceite de pescado que tiene valor Totox debajo de 20 y un contenido de omega-3 superior al 10% en peso con base en el peso total del aceite de pescado y en donde se utiliza una emulsionante adecuado pata estabilizar la emulsión, en donde los tipos de cáncer tratados se seleccionan entre el grupo que consiste en cáncer pancreático, cáncer colorrectal, cáncer neurológico, cáncer de mama, cáncer de próstata, cáncer de pulmón y cáncer de piel, y dicho postratamiento de cáncer comprende el tratamiento de la caquexia, la deficiencia de vitamina D, fatiga, o la estimulación del sistema inmunitario.
MX2015014713A 2013-04-22 2014-04-22 Uso de una composición que comprende aceite de pescado y jugo para el tratamiento y/o postratamiento de cáncer. MX370055B (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
NO20130552 2013-04-22
PCT/NO2014/050061 WO2014175748A1 (en) 2013-04-22 2014-04-22 Use of a composition comprising fish oil and juice for the treatment and/or post treatment of cancer

Publications (2)

Publication Number Publication Date
MX2015014713A MX2015014713A (es) 2016-06-06
MX370055B true MX370055B (es) 2019-11-29

Family

ID=50792503

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2015014713A MX370055B (es) 2013-04-22 2014-04-22 Uso de una composición que comprende aceite de pescado y jugo para el tratamiento y/o postratamiento de cáncer.

Country Status (19)

Country Link
US (2) US9877944B2 (es)
EP (1) EP2991507B1 (es)
JP (1) JP6495245B2 (es)
KR (1) KR102253929B1 (es)
CN (1) CN105120683A (es)
AU (1) AU2014258007B2 (es)
BR (1) BR112015025787B1 (es)
CA (1) CA2909409A1 (es)
DK (1) DK2991507T3 (es)
ES (1) ES2753387T3 (es)
HK (1) HK1221874A1 (es)
HR (1) HRP20191912T1 (es)
HU (1) HUE046885T2 (es)
LT (1) LT2991507T (es)
MX (1) MX370055B (es)
PL (1) PL2991507T3 (es)
PT (1) PT2991507T (es)
SI (1) SI2991507T1 (es)
WO (1) WO2014175748A1 (es)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2753387T3 (es) 2013-04-22 2020-04-08 Smartfish As Uso de una composición que comprende aceite de pescado y zumo para el tratamiento y/o tratamiento posterior del cáncer
AU2016247674A1 (en) * 2015-04-14 2017-10-19 Atossa Genetics Inc. Compositions and methods of treatment of breast disorders and estrogen-related disorders
NO20160913A1 (en) * 2016-05-27 2017-11-28 Smartfish As Use of a composition comprising marine oil and juice for improving muscle performance.
CA3228010A1 (en) 2016-10-03 2018-04-12 Houn Simon Hsia Compositions and methods for enhancing cancer radiotherapy
US10905724B2 (en) * 2017-06-13 2021-02-02 Houn Simon Hsia Compositions and methods for enhancing hyperthermia therapy
WO2018231937A2 (en) 2017-06-13 2018-12-20 Houn Simon Hsia Compositions and methods for enhancing cancer radiotherapy
WO2018231943A2 (en) 2017-06-13 2018-12-20 Houn Simon Hsia Compositions and methods for enhancing cancer chemotherapy
CN108208838A (zh) * 2018-03-09 2018-06-29 北京素维生物科技有限公司 一种掩味组合物及其用途
CN113413532B (zh) * 2021-07-01 2022-03-01 曾迎春 基于虚拟现实的癌症相关认知障碍评估与康复训练系统
CN115317543B (zh) * 2022-09-13 2023-05-23 复旦大学附属金山医院(上海市金山区眼病防治所、上海市金山区核化伤害应急救治中心) 一种治疗肝癌恶病质的中药组合物及其应用

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0175468A3 (en) * 1984-08-10 1987-07-22 Sentrachem Limited Eicosanoids for use in cancer therapy
GB9423625D0 (en) 1994-11-23 1995-01-11 Scotia Holdings Plc Fortified fruit juice
CA2260397A1 (en) * 1999-01-29 2000-07-29 Atlantis Marine Inc. Method of converting rendered triglyceride oil from marine sources into bland, stable food oil
JP2000281572A (ja) * 1999-03-30 2000-10-10 Bizen Kasei Kk 殺癌細胞剤及びこれを配合してなる組成物
US20020012710A1 (en) 1999-11-29 2002-01-31 Rimonest Ltd. Pomegranate products useful in improving health and methods of use thereof
US20020188024A1 (en) 2000-08-23 2002-12-12 Chilton Floyd H. Fatty acid-containing emulsion with increased bioavailability
NO317310B1 (no) 2003-02-28 2004-10-04 Bioli Innovation As Olje-i-vann emulsjonskonsentrat for ernaeringsformal, samt anvendelse derav.
GB0503684D0 (en) * 2005-02-23 2005-03-30 Ici Plc Emulsifiers and emulsions
ES2264886B1 (es) 2005-05-12 2008-02-01 Proyecto Empresarial Brudy, S.L. Utilizacion de acido docosahexaenoico para el tratamiento de enfermedades tumorales.
CN100418427C (zh) * 2005-09-13 2008-09-17 仙桃市泰尔生物科技开发有限公司 保健型鱼奶加工方法
US20090202679A1 (en) * 2005-11-29 2009-08-13 Pharmalogica As Composition comprising fish oil and juices
NO20081487L (no) * 2008-03-27 2009-09-28 Smartfish As Helsefremmende drikk
JP5872453B2 (ja) * 2009-04-17 2016-03-01 ナタク ファルマ エセ．エレ． フィタン酸含量が低く、ω−３脂肪酸に富む組成物
ES2753387T3 (es) 2013-04-22 2020-04-08 Smartfish As Uso de una composición que comprende aceite de pescado y zumo para el tratamiento y/o tratamiento posterior del cáncer

Also Published As

Publication number Publication date
HUE046885T2 (hu) 2020-03-30
HK1221874A1 (zh) 2017-06-16
LT2991507T (lt) 2019-12-10
BR112015025787A8 (pt) 2019-12-24
EP2991507B1 (en) 2019-08-07
CA2909409A1 (en) 2014-10-30
DK2991507T3 (da) 2019-11-04
PT2991507T (pt) 2019-11-12
KR20160008200A (ko) 2016-01-21
JP6495245B2 (ja) 2019-04-03
AU2014258007A1 (en) 2015-10-15
BR112015025787A2 (pt) 2017-07-25
WO2014175748A1 (en) 2014-10-30
AU2014258007B2 (en) 2019-01-17
JP2016517865A (ja) 2016-06-20
EP2991507A1 (en) 2016-03-09
ES2753387T3 (es) 2020-04-08
MX2015014713A (es) 2016-06-06
US10188622B2 (en) 2019-01-29
BR112015025787B1 (pt) 2021-01-12
US20180110749A1 (en) 2018-04-26
HRP20191912T1 (hr) 2020-01-10
KR102253929B1 (ko) 2021-05-20
CN105120683A (zh) 2015-12-02
US9877944B2 (en) 2018-01-30
PL2991507T3 (pl) 2020-02-28
US20160067202A1 (en) 2016-03-10
SI2991507T1 (sl) 2020-02-28

Similar Documents

Publication Publication Date Title
MX370055B (es) Uso de una composición que comprende aceite de pescado y jugo para el tratamiento y/o postratamiento de cáncer.
MX2015011899A (es) Metodos para el tratamiento de cáncer y prevención de resistencia a los fármacos para el cáncer.
MX2016015181A (es) Combinacion de un anticuerpo del receptor 4 de quimiocina anti-cc y un agonista de 4-1 bb para el tratamiento del cancer.
MX2015011606A (es) Metodo para tratar cancer y prevenir resistencia a farmacos contra cancer.
EP3504305A4 (en) SALT WATER TREATMENT SYSTEM PRODUCED BY OIL AND GAS WELLS
EA201992251A1 (ru) Противораковые вакцины и способы лечения с их применением
EA201590997A1 (ru) Соединения и способы их применения
NZ720769A (en) Anti-siglec-8 antibodies and methods of use thereof
IL266636B (en) Biologically stable cannabinoids and a method for increasing their physiological concentration
IL276733A (en) Use of Aribolin in cancer treatment
PH12015502469A1 (en) Fcrn-binding abolished anti-igf-ir antibodies and their use in the treatment of vascular eye diseases
AU363477S (en) Insect barrier device
SG11201509083YA (en) Oil-in-water emulsion composition and surface treatment method using same
PH12016501838A1 (en) Compounds and their methods of use
EA201691108A1 (ru) Хиназолин-thf-амины в качестве ингибиторов pde1
MX2016005473A (es) Metodos y composiciones para mejorar la funcion renal.
AU358921S (en) Blood processing device
NZ711523A (en) Use of sedoheptulose for prevention or treatment of inflammation
PH12015500468B1 (en) Treatment and prevention of acne
AU2014353885A8 (en) Prevention and treatment of toxicosis
AU355724S (en) Tensioner bracket
UA115417U (xx) Спосіб профілактики та лікування гіпоксичних змін при карбоперитонеумі
TH1501006717B (th) องค์ประกอบอิมัลชั่นชนิดน้ำมัน-ใน-น้ำและวิธีการปรับสภาพพื้นผิวโดยใช้สิ่งนั้น
TH182669B (th) วิธีการบำบัดโรคมะเร็งโดยการใช้ตัวยับยั้ง tigit และสารต้านโรคมะเร็ง
AU360384S (en) Animal treat dispenser

Legal Events

Date Code Title Description
FG Grant or registration